Industry Analysis Reports | Health Care | Medical Devices

Tuesday 6 July 2021

Anti-Ageing Drugs Market Size, Share, Trend, Data Statistics Analysis by 2027

Market Synopsis of Global Anti-ageing drugs Market

“Botox has helped her get ready faster!” said Kelly Ripa on the show “Watch What Happens Live with Andy Cohen”. Gone is the time when one would find anti-ageing products only in the cabin baggage of international flights and the makeup rooms of top notch artists! Anti-aging drugs are used to slow down or reverse the process of aging in order to extend the lifespan. Anti-ageing drugs are no longer taboo even in dusky small towns. Today’s women even from developing countries are as modern and demanding as their western counterparts. Thus we expect the differential between west and east regarding anti-ageing drugs to fall from its colossal heights of the 80’s! The global anti-ageing drugs market is expected to reach USD 124,896.6 million by 2023, and the market is projected to grow at a CAGR of ~ 13.3 % during the forecast period 2017-2023.

Market dynamics of Global Anti-ageing drugs Market

The global anti aging industry statistics is driven by factors such as the rising number of ageing population, growing demand for anti-aging drugs, influence of media and fashion industry, and primal demand to be young. The social and attitudinal aspects of a region or nation also have a large impact on the market and so is the influence of the media. Anti-aging drugs market is currently in its infant stage and there is a lot of scepticism about its future. According to the World Health Organization (WHO), the proportion of the world's population over 60 years between 2015 and 2050 will nearly double from 12% to 22%. Further, as per WHO estimates, by 2020, the number of people aged 60 years and older will outnumber children younger than 5 years and by 2050, 80% of older people will be living in low- and middle-income countries.

Critical market constraints are scepticism, concerns of safety, stringent regulations and definition ambiguity etc. Many spurious products with dubious claims are easily available on the web that has spurred a flood of self-proclaimed experts proposing growth hormones, skin-care products, beta glucan, and a variety of dietary and nutritional supplements with claims that are difficult to validate. The definition issues are also huge as the Food and Drug Administration has repeatedly warned many producers of anti-ageing medicines of such claims. The definition of cosmeceuticals is not agreed by many administrative bodies. There are issues of counterfeit products and misbranding, which reduces the market for quality products from reputed manufacturers. Lack of experimental studies to validate the claims made by manufacturers has complicated the situation.

Market strategies of players

Brand awareness and brand loyalty plays a critical role in the global anti-ageing drugs market. Established market players must focus on the product development as well as market development strategies. Maintaining market equity is of utmost importance as the market is highly integrated and specialized. Lack of any effective drug is likely to make any novel drug an immediate market leader with minimal marketing cost and efforts.

Collaboration and distribution agreements are another strategies taken by players. For example, Lakme has joined hands with HLL so as to reduce competition from similar brands from other companies. Cashing in on a single brand so as to build market position, brand and future market equity is an attractive market entry strategy.

Segments of Global Anti-ageing drugs Market

The global anti-ageing drugs market has been segmented on the basis of drug class and applications. On the basis of drug class, the market is segmented into serums and supplements, antioxidants and enzymes, stem cells and drugs. On the basis of application, the market is segmented into skin and hair, skeletal and muscles, age related disorders and others.

Serums and supplements segment commanded the largest market share in 2016 and is expected to reach USD 51,590.5 million by the end of 2023. Furthermore, stem cells segment is expected to be the fastest growing market which is expected to grow at a CAGR of 16.6 % during the forecast period 2017-2023. Skin and hair segment commanded the largest market share in 2016. This market is expected to reach USD 72,222.3 million by 2023, at a CAGR of 15.9 % during the forecast period 2017-2023

Regional Analysis of Global Anti-ageing drugs Market

The Americas holds a significant market share followed by Europe. The high per capita income of the US, the presence of large innovative players in healthcare of the U.S. regions drive the anti-ageing drugs market. The ageing population of baby boomers is expected to propel the market in the US. North America held the largest market share in 2016. This market is expected to reach USD 42,470.5 million by 2023, at a CAGR of 13.4 % during the forecast period of 2017-2023

Europe is the second largest market in the globe due to a high healthcare expenditure and influence of media industry. Asia Pacific region is expected to grow rapidly; Japan, China and India are likely to lead the market due to unmet needs during the forecasted period. APAC is expected to grow at a higher CAGR of 15.3 % than the other regions because of increasing ageing population in this region.

Gulf nations such as Saudi Arabia and the UAE drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

Key Players in the Global Anti-Ageing Drugs Market

Some of key players profiled in the report are Nu Skin, BIOTIME, INC., Elysium Health Inc., La Roche-Posay, DermaFix, L'ORÉAL, and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

GallBladder Treatment Market, Segments, Growth And Value Chain Analysis 2027

Market Insights

Gall bladder diseases afflict a significant number of people on a regular basis. In 2013 more than 100 million people were diagnosed with gallbladder and related diseases which resulted in more than 100,000 deaths. The gall bladder is a vital organ which stores bile produced by the liver and pass it along a duct which then empties into the small intestine. Market Research Future has dedicated valuable resources to the research of the global gall bladder treatment market. Calculation regarding market growth reveals a CAGR of 6.5% during the forecast period between 2017 and 2023. The market is expected to reach an evaluation of USD 27,121.5 Mn by the end of 2023.

The biggest driver of the gall bladder treatment market is the increasing prevalence of gall bladder diseases caused primarily by a sedentary lifestyle and/or poor lifestyle habits. Aggressive alcohol abuse or poor eating habits are likely to trigger gall bladder diseases. The increasing prevalence of gall bladder disease has resulted in increased awareness with regards to gall bladder diseases and treatment and has driven high demand for effective gall bladder treatment. The adoption of advanced diagnostic has also encouraged the demand for advanced treatment options which are minimally invasive. Moreover, the presence of a large and rapidly growing geriatric population is expected to have a significant impact on the market in a positive manner. Emerging economies are prime regions for the expansion of the market, and they display high opportunity for growth during the forecast period.

Despite healthy growth during the forecast period, the complications and pain associated with gall bladder surgery and recovery, combined with the asymptomatic nature of gallstones will likely slow market growth during the assessment period.

GallBladder Treatment Market Segmentation

The global gall bladder cancer treatment market is segmented on the basis of disease indication, diagnosis, treatment, end-users, and region. On the basis of disease indication the global gall bladder treatment market has been segmented into gallbladder polyps, gallbladder cancer, cholecystitis & biliary colic, gall stone, and cholelithiasis & choledocholithiasis. Gallstones make up 24.5% of the total share of the market making the gallstones segment the largest segment.

Diagnosis has been segmented into computerized tomography (CT), ultrasound, blood tests, and cholangiography & hepatobiliary scintigraphy. The ultrasound segment is captured maximum market share. However, the CT segment is projected to witness growth at a CAGR of 7.10% during the review period.

Treatment has been divided between surgery and drugs. Surgery accounts for the most significant share of the market by treatment and is expected to reach a substantial market value by the end of 2023.

End-users include hospitals & gynecology clinics, and academic & research centers.

GallBladder Treatment Market Regional Analysis

North America has reached the forefront of the global market due to the presence of a significant patient population which is afflicted by gall bladder disease. In North America, the U.S holds the largest market share. Developed economies tend to have a higher prevalence of gallbladder diseases. Europe is the second largest regional market for gall bladder treatment. The presence of a developed healthcare sector and high healthcare expenditure has secured Europe its leading market position. Meanwhile, the Asia Pacific is growing in prominence as a regional market in the global market for gall bladder treatment. Awareness regarding gall bladder disease and the increased demand for treatments as well as the presence of a massive patient population is expected to drive the APAC market. APAC is expected to grow at a CAGR of 7.0% during the review period.

GallBladder Treatment Market Key Players

Dornier MedTech, Boston Scientific Corporation, B. Braun Melsungen AG, Sanofi, Intuitive Surgical, Koninklijke Philips N.V., C. R. Bard, Inc. and others have been identified and included in MRFR's analysis of the competition in the global gall bladder treatment market.

Browse Complete Report With Toc @ https://www.marketresearchfuture.com/reports/gallbladder-treatment-market-3945

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Monday 5 July 2021

Dermal Fillers Market 2027 Industry Size, Share, Growth, Development Trends, Top Leading Companies, Future Opportunities and Forecast Research

The fda-approved dermal fillers market has been witnessing continuous growth over the past few years. The strong consumer preferences to achieve a youthful appearance and look by reconstructing contour deformities in the face is a major driving force behind the growth of the market. People are increasingly becoming conscious about their looks, and the dynamics of beauty are changing rapidly.

Also, factors such as the influence of fashion, media & entertainment industry, and peer pressure for appearance & beauty encourage the adoption of dermal filling procedures. Looking at the growth in the dermal fillers market share, Market Research Future (MRFR) asserts that the global dermal fillers market size is poised to increase to USD 6,899.16 MN by 2025. In its recently published dermal fillers market report, MRFR also states that the market would register around 13.2% CAGR throughout the review period (2016 – 2022).

Also, the rapidly dropping dermal fillers cost and prices of dermal filler ingredients & lip fillers are substantiating the growth of the market. Owing to their non-invasive nature, dermal filling procedures are garnering massive popularity worldwide, which drives the dermal fillers market growth excellently. With the advances in medical science & technology, dermal fillers have evolved greatly, offering more than just supplements that increase facial volume and reduce wrinkles & folds.

There has been a significant rise in the number of treatments performed across the globe each year. Subsequently, once considered as a part of the cosmetic surgery, dermal fillers treatments have now emerged as mainstream procedures. Rising demand for dermal fillers treatments alongside the developments in the facial rejuvenation industry fosters the market growth largely.

Additionally, factors such as the growing aging population and rapid urbanization are substantiating the market growth. Also, rapid increase in the global economy is impacting the market growth positively. Furthermore, the growing prevalence of obesity & accidents, alongside the increasing numbers of facilities & centers offering dermal fillers procedures and the safety margin, are the major tailwinds pushing the growth of the market.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/3893

Increasing number of cosmetic surgeries as well as lifestyle changes further accelerate the market growth. There is an increases in the number of facial injectable surgeries performed on women, as their demand is increasing from last few years, thus boosting the development of the market. Around 91% of facial injectable surgeries are performed on women across the globe. Additionally, availability of well qualified and highly skilled healthcare professional such as dermatologist and surgeons increase the demand for dermal fillers and other dermatology devices and appliances in the market.

Technological advancement further determines the development of dermal fillers market as the key players are now engaged in product differentiation strategy, which is important to sustain the company`s growth and strength its geographical presence.

Key Players in The Dermal Fillers Market:

ALLERGAN (Republic of Ireland), Dr. Korman Laboratories (Israel), GALDERMA (Switzerland), Integra Lifesciences (US), Merz Pharma (Germany), Sinclair Pharma (UK), and Teoxane laboratories (Switzerland). The major players focus on the development of products useful for particular segment such as nutritional products for adults, children and geriatric population. The major players focus on the development of products useful for particular segment such as nutritional products for adults, children and geriatric population.

Key Developments:

Strategic approaches adopted help the major players in the market to sustain their growth and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players. This help the companies to reach untapped markets in developing nations of the worlds, thus reducing the supply demand gap.

ALLERGAN:

Allergan has a wind range of products which provides efficient treatment for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories

June 2017: Allergan announces launch of artificial tear refresh optive mega-3.

June, 2017: Allergan announced the acquisition of Keller Medical, adding Keller Funnel to co's leading plastic surgery portfolio.

March 2017: Allergan and Editas Medicine enter into strategic research and development alliance. This alliance is to discover and develop Crispr Genome editing medicines for eye diseases.

Galderma:

Galderma is a global leader in dermatology and has strategic partnerships with brands like Soolantra, Tri-Luma, Loceryl, BenzacEpiduo, Oracea, Differin, Mirvaso, Cetaphil, Excipial, Daylong, Restylane, Emervel and many other brands. The company focus on the production of innovative solutions in the field of dermatology for the treatment of various skin diseases such as acne, rosacea, psoriasis, steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and other various fields in skin care.

January 2017: Galderma launched two new dermal fillers. In December, Galderma received FDA approval for a pair of next-generation hyaluronic acid (HA) dermal fillers: Restylane Refyne and Restylane Defyne.

January 2017: Galderma announces approval of Azzalure in Europe for treatment of lateral canthal lines in adults. Azzalure, a product in-licensed from Ipsen, received positive opinion from the French regulatory authority, ANSM, for treatment of lateral canthal lines (crow’s feet), either alone or in combination with treatment of glabellar lines.

July 2016: Chugai and Galderma Announce Global License Agreement for Nemolizumab (CIM331), Novel Biologic for Skin Diseases. The primary aim of this agreement is to improve atopic dermatitis by breaking the itch-scratch cycle which has great expectation for nemolizumab.

January 2016: Maruho and Galderma to Join Forces in a Strategic Alliance in Japan. One of the major reasons of this strategic alliance is that galderma will permit maruho to additionally promote their products in japan in the field of dermatology.

Integra Lifesciences:

February 2017: Integra Lifesciences plans to acquire Codman neurosurgery business from Johnson & Johnson.

February 2016: Integra Lifesciences Holdings Corp announces Service Alliance Agreement with PREZIO Health. By this Integra life science will have an authorized service provider for surgical devices and instruments.

May 2015: Integra Lifesciences completes acquisition of TEI Biosciences and TEI Medical. This acquisition Integra will expand their biomedical product profile with collagen based products strengthening the product portfolio of Integra Life Science.

Browse Full Report @ https://www.marketresearchfuture.com/reports/dermal-fillers-market-3893

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Anaesthesia delivery devices market- Trends, Demand, Global Analysis by Top Companies

Overview:

The anaesthesia delivery devices market, as Market Research Future (MRFR), suggests is all set to achieve 8.2% CAGR during the forecast period (2017-2023). Anaesthesia delivery devices play a pivotal role during a medical surgery where it helps in making the patient unconscious during the procedure. The device generates, blends, and delivers fresh medical gas flow with anaesthetic agents to have control over the entire process. The process often includes a mechanical ventilator, breathing system, suction equipment, and patient monitoring devices to ensure smooth workflow. MRFR in their detailed report on the said market included segmental analysis and factors that can impact the market in the coming years. The report also contains expert comments and updated information on the major market players’ portfolios.

The anaesthesia delivery devices market centers around the growing need for surgical procedure across the world as the prevalence of chronic diseases is on the rise. Advanced technologies are amply backing up the modern surgical requirements and, in the process, are fostering growth for the market. However, the supply-demand relationship is facing some crises globally. Both the developed and developing countries are facing a shortage regarding anaesthesia delivery devices. Manufacturers across the globe are trying to figure out some sort of solution. One such is the integration of artificial intelligence (AI) that can ensure specific delivery and reduce the cost in the process. Such technological association can surely guide the anaesthesia delivery devices market to better prospects.

Segmentation:

As described in the MRFR report, the global anaesthesia delivery devices market can be segmented by types and end-users.

Based on types, the anaesthesia delivery devices market can be segmented monitoring devices, anaesthesia delivery devices, disposables device and other. The disposables device segment includes anaesthesia masks and anaesthesia accessories.

Based on the end-users, the anaesthesia delivery devices market comprises hospitals, clinics, research facilities, and others.

Regional Analysis:

Geographically, upon considering the inputs by MRFR on the anaesthesia delivery devices market, the report can be segmented by Asia Pacific (APAC), Europe, North America, and the Rest-of-the-World (RoW).

The APAC region is currently leading the global market, and the market demography is expected to remain the same. This can happen as the regional market is also expecting the fastest CAGR during the forecast period. Countries such as India and China, with their revamped healthcare sector and the huge population has tapped into a vast patient pool who require surgeries of different sorts. In the process, they have widened the scale in which the anaesthesia delivery devices market can operate.

North America can take credit for being the second largest market. Its substantial revenue can be attributed to the advanced technologies, easy accessibility to products & services, and the emphasis on providing the best equipment in the industry is fostering the growth in the region.

Europe has considerable control over the global market as many of the manufacturing companies are from the region. Countries such as the UK, Germany, and France, are boasting off their advanced technology, affordability power, and government initiatives in research and development sector can trigger good responses from the regional market in the coming years.

Competitive Landscape:

Notable market players operating in the global anaesthesia delivery devices market are MEDTRONIC (Republic of Ireland), Teleflex (US), MAQUET Holding B.V. & Co. KG. (Germany), Smiths Medical (UK), GE Healthcare (US), Sedana Medical (Sweden), Drägerwerk AG & Co. (Germany), OSI Systems (US), ResMed (US), Fisher, Paykel (New Zealand), Philips Healthcare (Netherland), Intersurgical Ltd (UK), Covidien plc (UK), Getinge Group (Sweden) and others.

In August 2018, Hologic came up with a fluid management system with an aim to help in hysteroscopic procedures. The setup has a modern touchscreen and almost noiseless functioning ability. Fluid capacity, deficit, and how much content left in the fluid bag would get displayed on the monitor that would ease the entire process.

Access Report Details @ https://www.marketresearchfuture.com/reports/anesthesia-delivery-devices-market-1285

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

eHealth Market Trends, Size, Share and Regional Demand by 2027

Overview:

The global e health market size is slated to surpass USD 270 billion by 2023, with a 12.9% CAGR during the forecast period (2018-2023). Market Research Future (MRFR) discussed various factors in the report that would trigger a rise in the ehealth services market share.

Market Drivers:

Among prominent drivers, facilities of providing consultation from a distance, reducing the waiting time, curbing the chances of contracting contagious diseases, better digital facilities, and others are expected to set up the market for better momentum. Its ability to reduce cost, pressure from hospitals, and improve quality are expected to boost market growth. In emerging countries, governments are spending more on infrastructure to clear a path for better integration of this system, which will propel the expansion rate of the market.

However, its initial cost of installation and lack of digital awareness among the people from the elderly generation and in rural areas can prohibit market growth.

Segmentation:

The global ehealth services market has been studied by MRFR experts and their report reveals a segmentation based on type, end user, and service. This is going to help in understanding the ehealth digital service infrastructure.

By type, the global market for e-health services includes ePrescribing, Electronic Health Records (EHR), big data systems, Telemedicine, Consumer health IT, Clinical Decision Support System (CDSS), and Knowledge Management System (KMS).

By service, the global market for ehealth services has been segmented into clinical services, administrative services, and financial services.

By end user, the global market report deals with segments like health insurance companies, clinics, hospitals, and others.

Regional Analysis:

The Americas can retain its dominance by providing backup to the system with proper digital support and funding. In the US and Canada, this market will gain more. In Europe, this market will be backed by Italy, France, Germany, the UK, and other affluent countries.

Competitive Landscape:

The potential of the eHealth market is huge and is rightly getting explored by top companies like Allscripts Healthcare Solutions Inc. (U.S), IBM Corporation (U.S), McKinsey & Co. (U.S), GE Healthcare (U.S), Epocrates Inc. (U.S), Telecare Corp. (U.S), Motion Computing Inc. (U.S), Apple (U.S), Boston Scientific Corp (U.S), GE Healthcare (U.S), Proteus Digital Health (U.S), Cerner (U.S), and others. These companies are creating grounds for further exploration both in terms of reach and product portfolio using methods like mergers, innovations, branding, partnerships, acquisitions, hiking the investment for research-related activities, and others.

Industry News:

The impact of the COVID-19 crisis has been substantial in the healthcare sector. The industry is witnessing some upheaval in structure as several options are getting tailwinds to normalize the process after the initial disruption. This pandemic crisis was all too sudden and in most of the countries, people were not prepared to handle it at all. Its presence among the people is threatening as the disease is contagious. That is why people around the world were advised to maintain social distancing, which is true in the healthcare sector as well. This has triggered a growth in ehealth or digital health. In fact, to back it up with adequate connectivity, companies are increasing their expenditures and forming collaborations. For instance, in June 2020, a report came out declaring the extension of the collaboration between SkyNet and SES Networks to support the Colombian Amazonas where businesses, government entities, local residents, and the San Rafael de Leticia Hospital are all benefiting from this joint venture and modification in net speed.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact:

Market Research Future

Phone:

+1 628 258 0071(US)

+44 2035 002 764(UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com

Nanomedical devices and therapeutics market 2027- Analysis and Forecast

Nanomedical devices are the modern version of those devices that are useful for the diagnosis and treatment of diseases. Market Research Future (MRFR) has published and released a research report regarding the global nanomedical devices market that calculates growth for this market with 10.29% CAGR between 2017 and 2023.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/1236

This report analyzes the market structure and offers insights about factors affecting the market growth. Evaluating market size and forecasting the revenue, this reports covers and observes the competitive developments of market players that include joint ventures, mergers and acquisitions, new product developments, research and developments (R & D), and strategic alliances.

The primary factors driving the growth for global nanomedical devices market include steep growth in the development of nanomedical devices, increasing healthcare expenditure, increasing the prevalence of cancer & other chronic diseases, and the introduction of nanotechnology-based cardiac & orthopedic implants in the markets. However, the high cost of the treatment and lack of regulatory standards in the examination of nanoparticle-based medicines can restrain the market growth.

The global nanomedical devices and therapeutics market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular diseases neurological diseases, and other. With regards to end users, the market has been segmented into clinics, hospitals, and research institutions. By types, the market segmentation covers implantable biosensors, implantable cardioverter-defibrillators, implantable drug delivery system, and others.

The regional segmentation of the global nanomedical devices market segments the market into continent-based regional markets namely The Americas (North America & South America), Asia Pacific, Europe, and the Middle East & Africa (MEA). The biggest regional market is The Americas. North America alone holds the potential to be the largest market due to its strong economies are known as the United States of America (USA) and Canada. Individually, North America is a bigger market than South America due to the availability of advanced technology. Other factors aiding the market growth in this region include increasing governmental support for the research and development (R&D) as well as rising healthcare expenditure.

In Europe, the market growth is primarily driven by more awareness and advancement in the nanotechnology sector. Europe has a high density of population, and after North America, it has maximum technological advancement. Due to the reasons same as The Americas, Western Europe as a market is bigger than Eastern Europe. The most important country-specific markets in Europe are Germany, France, Spain, Italy, and the United Kingdom (UK), followed by the rest of Western Europe.

According to the report, the Asia Pacific is expected to emerge as the fastest growing regional market during the forecast period. The reasons for the market growth are increasing demand for better treatment options and increasing initiatives to include Information Technology (IT) in all sectors including healthcare. The primal country-specific markets in this region are Australia, China, India, South Korea, and Japan, followed by the rest of the Asia Pacific region.

The MEA region shows limited market slow and steady growth. The reasons for the slow market growth in this region are lack of awareness, lack of education, lack of technological development, political instability, poor healthcare facilities, and healthcare not considered a priority by most governments. The crucial country-specific markets in the MEA region are Kuwait, Oman, Saudi Arabia, United Arab Emirates (UAE), and Qatar, followed by the rest of the MEA region.

Access Report Details @ https://www.marketresearchfuture.com/reports/nanomedical-devices-market-1236

Key Players

The key players global nanomedical devices market include 3M Company (USA), EnvisionTEC (USA), EOS GmbH (Germany), Medtronic (USA), PerkinElmer, Inc. (the USA), Smith & Nephew PLC (UK), St. Jude Medical, Inc. (the USA), Starkey Hearing Technologies (USA), and Stryker Corporation (USA).

Latest Industry News

Leading graphene biosensors manufacturer and biotherapeutics developer Nanomedical Diagnostics are developing Agile R100. This is a portable digital device useful for biosensing that can be employed for any click-able application. It evaluates the potential of the platform for identifying the biomarkers associated with aging, pathology, and tissue health. 16 OCT 2018

Houston Methodist scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. 23 OCT 2018

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Global Clinical Nutrition Market Trends, Size and Growth Analysis and Forecast

Market Overview

The Global Medical Nutrition Market 2020 is expected to reach USD 52.39 billion by 2023 and grow at a CAGR of 5.0% over the forecast period (from 2018 to 2023).

Market Highlights

The clinical nutrition market trends report asserts that the increased occurrence of diseases that need additional nutrients and increased population awareness of the benefits of medicated foods and beverages are the main factors impacting the growth of this market. The shortage of sufficient nutrients has resulted in shifting habits such as daily smoking, alcohol, longer working hours and dependence on fast food, which is also one of the factors contributing to the rise of the market for the medical nutrition industry. High price and important reimbursement policies adopted by the governments of different countries are however the factors that hinder business growth.

With the increasing geriatric population, it is anticipated that spending on medical nutrition therapy will increase in the future. Due to the frail digestive framework in old age, it becomes hard for the human body to assimilate all the essential nutrients from food. The lack of appetite among the geriatric community is considered a significant widespread concern, such that the elderly population does not get the essential amount of nutrients.

In most countries, healthcare spending continues to grow faster than economic growth, maintaining a trend observed over the decades. As healthcare spending increases among the world's major countries, the market is therefore expected to see high growth due to its broad applicability.

Segmental Analysis

Global clinical nutrition has been segmented into type, type of product, application, administration route, and channel of distribution.

Based on type, paediatric nutrition, elderly nutrition, parenteral nutrition, and sports nutrition were segmented into the medical nutrition market.

The medical nutrition market has been segregated into amino acid solutions, various vitamins, antioxidants, lipid emulsions, trace elements, and chamber bags based on the product type.

The medical nutrition market has been broken down into parenteral, oral, and others based on the route of administration.

Cancer, pulmonary diseases, gastrointestinal diseases, diabetes, obesity, paediatric malnutrition, renal failure, and neurological diseases were classified according to the application.

Hospitals, retail pharmacy, compounding pharmacy, and e-commerce websites were categorised based on the distribution channel.

Regional Overview

For the sake of the clinical nutrition report, the global medical nutrition market is split into the Americas, Europe, the Asia-Pacific, and the Middle East & Africa.

In the global market for medical nutrition, the American region holds the largest share. In North America, the US is anticipated to lead the market. The increase in the geriatric population is leading to many illnesses and disorders. Demand for the medical nutrition market is therefore expected to grow over the forecast period.

Europe accounted for the second-largest market share; however, 4.5 percent of the CAGR is expected to be the fastest-growing region in the Asia-Pacific during the forecast period. Asia-Pacific has the highest growth in the forecast period, compared to the other regions. Increases in the prevalence of metabolic disorders, an increase in the geriatric population in the Asia Pacific region, and high spending on healthcare are major factors attributable to the growth of the Asia Pacific clinical nutrition market. The incidence of diabetes in China is also growing steadily, which is a major factor in obesity. Over the past decade, the real number of patients diagnosed with metabolic disorders has increased, so the number of patients diagnosed has risen in the Asia Pacific region.

Competitive Dashboard

AYMES Nutrition International Ltd. (UK), Primus Pharmaceuticals (US), Abbott Nutrition (US), NeoMed (US), Baxter International (US), Nutricia Advanced Medical Nutrition (Netherland), Danone (France), Mead Johnson & Company, LLC. (US), Solace Nutrition (UK), B. Braun Melsungen AG (Germany), and Nestlé Health Science (Switzerland), are some of the major players operating in the global medical nutrition market.

About Market Research Future:

Contact:

Market Research Future

Phone:

+1 628 258 0071(US)

+44 2035 002 764(UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com

Industry Analysis Reports | Health Care | Medical Devices | Pharmaceutical

Labels

Tuesday 6 July 2021

Anti-Ageing Drugs Market Size, Share, Trend, Data Statistics Analysis by 2027

GallBladder Treatment Market, Segments, Growth And Value Chain Analysis 2027

Monday 5 July 2021

Dermal Fillers Market 2027 Industry Size, Share, Growth, Development Trends, Top Leading Companies, Future Opportunities and Forecast Research

Anaesthesia delivery devices market- Trends, Demand, Global Analysis by Top Companies

eHealth Market Trends, Size, Share and Regional Demand by 2027

Nanomedical devices and therapeutics market 2027- Analysis and Forecast

Global Clinical Nutrition Market Trends, Size and Growth Analysis and Forecast

Blog Archive

Total Pageviews